BN 05/08 16:37 *TEVA TALKING TO BANKS INCL. BARCLAYS, CITI, BOFA, HSBC ON LOAN
BN 05/08 16:36 *TEVA FINANCING MAY GIVE IT MEANS TO RAISE MYLAN BID: SOURCES
2015-05-08 16:36:52.901 GMT
--ELIZABETH FOURNIER
-0- May/08/2015 16:36 GMT
2015-05-08 16:23:00.23 GMT
--BETH MELLOR
-0- May/08/2015 16:23 GMT
S&P lowers Turkey local currency sovereign rating one notch from BBB to BBB- (lowest level of investment grade); outlook Negative - affirms foreign currency sovereign ratings at BB+The lowering of the local currency sovereign credit ratings on Turkey reflects what we consider to be increasing curbs on the operational independence of Turkey's central bank, which in our opinion have made it more challenging for the monetary authority to credibly fulfill its price stability mandate and to dampen the impact of exchange rate volatility on the economy's growth prospects. Another consequence of rising currency volatility, which reflects a less transparent monetary policy, is the re-dollarization of the financial sector's deposit base. Overall, we now consider that the challenged credibility of the central bank, including a weakened monetary transmission channel, has diminished the status of the Turkish lira as a reliable transactional currency; we think this poses greater risks to the refinancing of Turkey's considerable stock of external debt. While we consider that Turkey's relatively deep capital markets benefit its monetary flexibility, we view the complex monetary framework--with multiple interest rates and an unusually broad interest rate corridor--as relatively ineffective given the high pass-through of exchange rate depreciation into headline inflation.
Amazon’s delivery drone plans may have seemed more like a media stunt than a concrete vision back when it launched, but with active testing taking place in Canada and now, new details showing up in a patent application, things are getting real. The new proposed patent for an “Unmanned Aerial Vehicle Delivery System” (via BBC) contains some impressive revelations about Amazon’s proposed automated package transport plans.
For instance, the system would use location information shared by a package recipient’s smartphone to be able to zero in on their position and bring deliveries directly to them, regardless of whether they happen to be at home or somewhere else. You’d also be able to specific different locations as package destinations, giving you more flexibility about where to receive things depending on your schedule or needs at the exact time of delivery.
This would be a huge step up from the current situation in terms of convenience. At best, delivery services will call me the morning a package is set to arrive to provide a heads up, and let you modify your delivery day online. Being able to tweak it while the package is en route to match up with your exact plans hour-by-hour would take a lot of the unnecessary stress and worry out of the whole process.
Amazon’s patent also includes details around how it will use sensors, cameras, radar and more to guarantee the drones can land safely, and how it will monitor its path to avoid humans and other obstructions. But the key magic here, in terms of how the system would present an improvement for consumers as well as giving Amazon benefits vs. current old-school delivery methods, is that intelligent, adaptable route-shifting.
Of course, it also means Amazon will have to take extra precautions to ensure that it’s not easy for bad actors to manipulate drone routing to intercept packages. But if it does work, and work well, custom routing alone would change the face of ecommerce and consumer delivery.
BN 05/08 13:48 *MONSANTO:CONFIDENT IN ABILITY TO GET ALL REGULATORY APPROVALS
BN 05/08 13:46 *MONSANTO SAYS COMBINATION WOULD DELIVER SIGNIFICANT VALUE
BN 05/08 13:46 *MONSANTO CONFIDENT IN ABILITY TO OBTAIN NECESSARY REG APPROVALS
BN 05/08 13:46 *MONSANTO CONFIRMS PROPOSAL TO SYNGENTA’S BOARD
BN 05/08 13:46 *MONSANTO CONFIRMED PROPOSAL FOR 449.00 CHF/SHR
BN 05/08 13:46 *MONSANTO CONFIRMED MADE PRIVATE PROPOSAL TO SYNGENTA’S BOARD
BN 05/08 13:46 *MONSANTO COMMENTS ON PROPOSAL FOR SYNGENTA
2015-05-08 13:46:00.135 GMT
Monsanto Comments on Proposal for Syngenta
Business Wire
ST. LOUIS -- May 8, 2015
In response to Syngenta’s [VTX: SYNN] announcement this morning, Monsanto
Company [NYSE:MON] today confirmed that it had made a private proposal to
Syngenta’s Board of Directors to acquire Syngenta for 449.00 CHF per share.
The proposal contemplates consideration of approximately 45% cash and would
provide Syngenta shareholders with a very attractive premium and significant
further value creation through ongoing ownership in the combined company.
Monsanto has long respected and followed Syngenta’s business and believes
combining the two companies would deliver significant value to all
stakeholders, including shareholders. Creating a new company from the
combination of Syngenta’s strengths and leadership in crop protection
chemicals and Monsanto’s leadership in seeds, traits and information
technology would form an integrated global leader in agriculture with
comprehensive and complementary product portfolios, and an Ag-focused
organization with enhanced abilities to develop and accelerate innovative
solutions for growers. Monsanto believes the combined company would be
uniquely positioned to deliver a comprehensive suite of integrated solutions
to farmers around the world and to accelerate technological innovation through
precision agriculture and advanced research and development capabilities aimed
at increasing the world’s food supply in a sustainable fashion.
Monsanto believes a combination would deliver significant value to
shareholders of both companies. The combination is expected to result in
substantial synergies as the company delivers more integrated solutions to
customers.
Monsanto, in conjunction with its financial and legal advisors, has devoted
significant time and resources to analyzing a potential combination of
Syngenta and Monsanto and is confident in its ability to obtain all necessary
regulatory approvals.
Monsanto does not intend to make any additional comments on this matter at
this time.
About Monsanto Company
Monsanto is committed to bringing a broad range of solutions to help nourish
our growing world. We produce seeds for fruits, vegetables and key crops –
such as corn, soybeans, and cotton – that help farmers have better harvests
while using water and other important resources more efficiently. We work to
find sustainable solutions for soil health, help farmers use data to improve
farming practices and conserve natural resources, and provide crop protection
products to minimize damage from pests and disease. Through programs and
partnerships, we collaborate with farmers, researchers, nonprofit
organizations, universities and others to help tackle some of the world’s
biggest challenges. To learn more about Monsanto, our commitments and our more
than 20,000 dedicated employees, please visit: discover.monsanto.com and
monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo, on
the company blog, Beyond the Rows® at monsantoblog.com or subscribe to our
News Release RSS Feed.
Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are “forward-looking statements,”
such as statements concerning the anticipated financial results, current and
future product performance, regulatory approvals, business and financial plans
of the company and the potential combined business of the company and
Syngenta, including the expected benefits of a potential combination as well
as whether a potential combination will be entered into or completed, and
other non-historical facts. These statements are based on current expectations
and currently available information. However, since these statements are based
on factors that involve risks and uncertainties, the company’s actual
performance and results may differ materially from those described or implied
by such forward-looking statements. Factors that could cause or contribute to
such differences include, among others: continued competition in seeds, traits
and agricultural chemicals; the company’s exposure to various contingencies,
including those related to intellectual property protection, regulatory
compliance and the speed with which approvals are received, and public
acceptance of biotechnology products; the success of the company’s research
and development activities; the outcomes of major lawsuits and the
previously-announced SEC investigation; developments related to foreign
currencies and economies; successful operation of recent acquisitions;
fluctuations in commodity prices; compliance with regulations affecting the
company’s manufacturing; the accuracy of the company’s estimates related to
distribution inventory levels; the recent increases in and expected higher
levels of indebtedness; the company’s ability to fund its short-term financing
needs and to obtain payment for the products that it sells; the effect of
weather conditions, natural disasters and accidents on the agriculture
business or the company’s facilities; the possibility that a potential
transaction involving Syngenta will not be entered into or will be pursued on
different terms and conditions, failure to obtain necessary regulatory
approvals or to satisfy any of the other conditions to a possible transaction,
failure to realize the expected benefits thereof, or the impact of changes in
business, financial, market, legal or other conditions; and other risks and
factors detailed in the company’s most recent periodic report to the SEC.
Undue reliance should not be placed on these forward-looking statements, which
are current only as of the date of this release. The company disclaims any
current intention or obligation to update any forward-looking statements or
any of the factors that may affect actual results.
Contact:
Monsanto Company
Media:
Sara Miller, 314-694-5824
or
Analysts:
Laura Meyer, 314-694-8148
or
Joele Frank, Wilkinson Brimmer Katcher
Steve Frankel or Scott Bisang, 212-355-4449
-0- May/08/2015 13:46 GMT
Gapping down
In reaction to disappointing earnings/guidance: AMDA -27.9%, KEYW -21.7%, FLDM -17.2%, PLNR -15.2%, TWOU -14.2%, BEBE -12.3%, BIOS -11.6%, POZN -8.7%, DXPE -8.5%, ABTL -8.4%, UBNT -8.3%, AVNW -7.9%, AVID -7.4%, MDVN -6.7%, MNST -6%, CNCE -5.1%, SPPI -4.9%, PSIX -4.8%, NVDA -4.1%, LIVE -3.5%, JD -3.3%, BBOX -3.1%, CST -3%, NOG -2.9%, CA -2.7%, JAZZ -2.5%, (Concert Pharmaceuticals and Jazz Pharmaceuticals (JAZZ) report results from their Phase 1 clinical study of JZP-386; studies do not support advancing into a later-stage clinical trial of JZP-386 at this time ), EGY -1.9%, TGI -1.9%, UEPS -1.8%, CERN -1.7%, WAIR -1.6%, TESO -1.6%, CROX -1.4%, MACK -1.3%, FATE -1.3%, HZNP -1.3%, CNTY -0.8%, HTGC -0.7%, STON -0.7%, NVAX -0.6%,
M&A news: CRM -3.5% (Microsoft (MSFT) not considering bid for CRM, according to Reuters)
Other news: LJPC-9.7% (announces it will discontinue development of its polysaccharide-based galectin-3 inhibitors, GCS-100 and LJPC-1010),ALDX -6.2% (prices its follow-on public offering of 2,700,000 shares of its common stock at $7.50 per share), CNCE -5.1% (Concert Pharmaceuticals and Jazz Pharmaceuticals (JAZZ) report results from their Phase 1 clinical study of JZP-386; studies do not support advancing into a later-stage clinical trial of JZP-386 at this time ), HMTV -3.1% (prices secondary public offering of ~3.2 mln shares of Class A common stock at $12 per share), CEMP -1.6% (filed mixed securities shelf offering), TSLA -1.2% (small pull back from recent strength), SMLP -0.9% (priced public offering of 6.5 mln common units at $30.75 per unit)
Analyst comments: MHR -1.1% (downgraded to Neutral from Buy at Citigroup), TWO -0.8% (downgraded to Mkt Perform from Outperform at Keefe